Health Care

Mylan Shares Fall the Most in a Year as Loss Widens After an Acquisition Mylan Inc., the largest U.S. maker of generic medicines, had its biggest drop in 2 1/2 months on the New York Stock Exchange after acquisition expenses caused the company's first-quarter loss to widen.

Takeda Expects Profit to Fall 55% This Year on Millennium Takeover Costs Takeda Pharmaceutical Co., Japan's largest drugmaker, expects a 55 percent decline in profit this fiscal year because of costs from the $8.8 billion takeover of Millennium Pharmaceutical Inc. last month.

Sanofi, Bristol-Myers Fall on Swiss Competitor's Plan for Generic Plavix Sanofi-Aventis SA and Bristol-Myers Squibb Co. dropped the most in three months in stock market trading after a Swiss competitor said it plans to market a lower-priced copy of the blood thinner Plavix in Germany.

Heart Attack Risk Can Be Heard as Well as Seen, Researchers Say in Lancet Heart attack risk can be heard by listening for a certain noise in the artery supplying blood to the brain, U.S. researchers said.

Adolor Says U.S. FDA Won't Act Today on Entereg and Will Decide `Shortly' Adolor Corp. said regulators put off deciding whether to approve Entereg, the first U.S. treatment for constipation after intestinal surgery.

Roche's Actemra Reduces Joint Damage in Patients in New Arthritis Study Roche Holding AG, the world's biggest maker of cancer treatments, said its Actemra medicine limited structural damage to joints in a late-stage study of patients with rheumatoid arthritis.

Diabetes Patients Are Less Likely to Exercise Due to Arthritis, CDC Finds More than half of adult diabetics in the U.S. also have arthritis, which causes joint pain that may prevent the exercise they need to stay healthy, a study found.